Obliers A, Hinz R, Erbersdobler A (2014) Endometrioid borderline tumor of the testis. A rare cause of cystic neoplasia. Pathologe 35:504–507. https://doi.org/10.1007/s00292-013-1890-y
Article CAS PubMed Google Scholar
Young RH, Scully RE (1986) Testicular and paratesticular tumors and tumor-like lesions of ovarian common epithelial and Müllerian types. A report of four cases and review of the literature. Am J Clin Pathol 86:146–152. https://doi.org/10.1093/ajcp/86.2.146
Article CAS PubMed Google Scholar
Kernohan NM, Coutts AG, Best PV (1990) Cystadenocarcinoma of the appendix testis. Histopathology 17:147–154. https://doi.org/10.1111/j.1365-2559.1990.tb00686.x
Article CAS PubMed Google Scholar
Numakura K, Tsuchiya N, Tsuruta H, Obara T, Saito M, Inoue T et al (2011) A case of intratesticular endometrioid papillary cystadenocarcinoma. Jpn J Clin Oncol 41:674–676. https://doi.org/10.1093/jjco/hyr038
Coleman E, Radix AE, Bouman WP, Brown GR, de Vries ALC, Deutsch MB et al (2022) Standards of care for the health of transgender and gender diverse people, version 8. Int J Transgender Health 23:S1–S259. https://doi.org/10.1080/26895269.2022.2100644
Oh WK (2002) The evolving role of estrogen therapy in prostate cancer. Clin Prostate Cancer 1:81–89. https://doi.org/10.3816/CGC.2002.n.009
Article CAS PubMed Google Scholar
Beral V, Bull D, Reeves G, Million Women Study Collaborators (2005) Endometrial cancer and hormone-replacement therapy in the Million Women Study. Lancet 365:1543–1551. https://doi.org/10.1016/S0140-6736(05)66455-0
Article CAS PubMed Google Scholar
Collaborative Group on Epidemiological Studies of Ovarian Cancer (2015) Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies. Lancet 385:1835–1842. https://doi.org/10.1016/S0140-6736(14)61687-1
WHO Classification of Tumours Editorial Board (2022) Endometrioid tumours. Urinary and male genital tumours, 5th edn. International Agency for Research on Cancer, Lyon, pp 337–338
Tong GX, Devaraj K, Hamele-Bena D, Yu WM, Turk A, Chen X et al (2011) Pax8: a marker for carcinoma of Müllerian origin in serous effusions. Diagn Cytopathol 39:567–574. https://doi.org/10.1002/dc.21426
Nonaka D, Chiriboga L, Soslow RA (2008) Expression of Pax8 as a useful marker in distinguishing ovarian carcinomas from mammary carcinomas. Am J Surg Pathol 32:1566–1571. https://doi.org/10.1097/PAS.0b013e31816d71ad
Rambau PF, Kelemen L, Steed H, Ghatage P, Stuart GC, Köbel M (2017) Association of hormone receptor expression with survival in ovarian endometrioid carcinoma: biological validation and clinical implications. Int J Mol Sci 18:515. https://doi.org/10.3390/ijms18030515
Article CAS PubMed PubMed Central Google Scholar
Beckman EN, Pintado SO, Leonard GL, Sternberg WH (1985) Endometriosis of the prostate. Am J Surg Pathol 9:374–379. https://doi.org/10.1097/00000478-198505000-00008
Article CAS PubMed Google Scholar
Fukunaga M (2012) Paratesticular endometriosis in a man with a prolonged hormonal therapy for prostatic carcinoma. Pathol Res Pract 208:59–61. https://doi.org/10.1016/j.prp.2011.10.007
Martin JD, Hauck AE (1985) Endometriosis in the male. Am Surg 51:426–430
Oliker AJ, Harris AE (1971) Endometriosis of the bladder in a male patient. J Urol 106:858–859. https://doi.org/10.1016/s0022-5347(17)61418-6
Article CAS PubMed Google Scholar
Pinkert TC, Catlow CE, Straus R (1979) Endometriosis of the urinary bladder in a man with prostatic carcinoma. Cancer 43:1562–1567. https://doi.org/10.1002/1097-0142(197904)43:4%26lt;1562::aid-cncr2820430451%26gt;3.0.co;2-w
Article CAS PubMed Google Scholar
Schrodt GR, Alcorn MO, Ibanez J (1980) Endometriosis of the male urinary system: a case report. J Urol 124:722–723. https://doi.org/10.1016/s0022-5347(17)55627-x
Article CAS PubMed Google Scholar
Taguchi S, Enomoto Y, Homma Y (2012) Bladder endometriosis developed after long-term estrogen therapy for prostate cancer. Int J Urol 19:964–965
Article CAS PubMed Google Scholar
González RS, Vnencak-Jones CL, Shi C, Fadare O (2014) Endomyometriosis (“uterus-like mass”) in an XY male: case report with molecular confirmation and literature review. Int J Surg Pathol 22:421–426. https://doi.org/10.1177/1066896913501385
Giannarini G, Scott CA, Moro U, Grossetti B, Pomara G, Selli C (2006) Cystic endometriosis of the epididymis. Urology 68:203.e1-203.e3. https://doi.org/10.1016/j.urology.2006.01.017
Jabr FI, Mani V (2014) An unusual cause of abdominal pain in a male patient: endometriosis. Avicenna J Med 4:99–101. https://doi.org/10.4103/2231-0770.140660
Article PubMed PubMed Central Google Scholar
Simsek G, Bulus H, Tas A, Koklu S, Yilmaz SB, Coskun A (2012) An unusual cause of inguinal hernia in a male patient: endometriosis. Gut Liver 6:284–285. https://doi.org/10.5009/gnl.2012.6.2.284
Article PubMed PubMed Central Google Scholar
Zámečník M, Hoštáková D (2013) Endometriosis in a mesothelial cyst of tunica vaginalis of the testis. Report of a case. Cesk Patol 49:134–136
Rei C, Williams T, Feloney M (2018) Endometriosis in a man as a rare source of abdominal pain: a case report and review of the literature. Case Rep Obstet Gynecol 2018:2083121. https://doi.org/10.1155/2018/2083121
Article PubMed PubMed Central Google Scholar
Al-Obaidy KI, Idrees MT (2019) Endometriosis with cystic degeneration: a rare disease of males. Int J Surg Pathol 27:311–314. https://doi.org/10.1177/1066896918797438
Xia QD, Zhang SH, Zeng N, Lu YC, Qin BL, Wang SG (2023) Novel androgen receptor inhibitors for metastatic hormone-sensitive prostate cancer: current application and future perspectives. Biomed Pharmacother 168:115806. https://doi.org/10.1016/j.biopha.2023.115806
Article CAS PubMed Google Scholar
Stein M, Goodin S, Doyle-Lindrud S, Silberberg J, Kane M, Metzger D et al (2012) Transdermal estradiol in castrate and chemotherapy resistant prostate cancer. Med Sci Monit 18:CR260–CR264. https://doi.org/10.12659/MSM.882626
Article CAS PubMed PubMed Central Google Scholar
Langley RE, Gilbert DC, Duong T, Clarke NW, Nankivell M, Rosen SD et al (2021) Transdermal oestradiol for androgen suppression in prostate cancer: long-term cardiovascular outcomes from the randomised Prostate Adenocarcinoma Transcutaneous Hormone (PATCH) trial programme. Lancet 397:581–591. https://doi.org/10.1016/S0140-6736(21)00100-8
Comments (0)